ConductScience.org, home

Paper42292467

Study of JCAD for prognosis and immune infiltration in hepatocellular carcinoma.

Wang Z and 8 others. Front Immunol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Study of JCAD for prognosis and immune infiltration in hepatocellular carcinoma. Papers, record 42292467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42292467

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Study of JCAD for prognosis and immune infiltration in hepatocellular carcinoma.
PubMed
Journal
Front Immunol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang ZZhonghua
2Tang JJing
3Zhu SSiyuan
4Li SShan
5Yao BBingyue
6Tu JJiayi
7Zhou XXingyue
8Tang QQinghe
9Zhong LLan

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Biomarkers, TumorMajor topic
Lymphocytes, Tumor-InfiltratingMajor topic
Humans
Prognosis
Female
Male
Gene Expression Regulation, Neoplastic
Tumor Microenvironment
Computational Biology

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140682115SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40682115PubMed
240702000RBM17 promotes hepatocellular carcinoma progression by regulating lipid metabolism and immune microenvironment: implications for therapeutic targeting.Cell Death Discov2025https://conductscience.org/library/papers/40702000PubMed
338086932Therapeutic induction of antigen-specific immune tolerance.Nat Rev Immunol2024https://conductscience.org/library/papers/38086932PubMed
439950116Deciphering the heterogeneity and plasticity of the tumor microenvironment in liver cancer provides insights for prognosis.Front Pharmacol2025https://conductscience.org/library/papers/39950116PubMed
539692577Down-regulation of JCAD Expression Attenuates Cardiomyocyte Injury by Regulating the Wnt/β-Catenin Pathway.Folia Biol (Praha)2024https://conductscience.org/library/papers/39692577PubMed
633237311The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets.Nucleic Acids Res2021https://conductscience.org/library/papers/33237311PubMed
728775168JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.Cancer Res2017https://conductscience.org/library/papers/28775168PubMed
838898190Higher inflammatory response in hepatocellular carcinoma is associated with immune cell infiltration and a better outcome.Hepatol Int2024https://conductscience.org/library/papers/38898190PubMed
938509842JCAD deficiency delayed liver regenerative repair through the Hippo-YAP signalling pathway.Clin Transl Med2024https://conductscience.org/library/papers/38509842PubMed
1029092952TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.Cancer Res2017https://conductscience.org/library/papers/29092952PubMed
1136727075Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma.Front Oncol2022https://conductscience.org/library/papers/36727075PubMed
1236181081Characterizing inflammatory markers in highly aggressive soft tissue sarcomas.Medicine (Baltimore)2022https://conductscience.org/library/papers/36181081PubMed
1338350421Precision treatment in advanced hepatocellular carcinoma.Cancer Cell2024https://conductscience.org/library/papers/38350421PubMed
1438742112
Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
Front Immunol2024https://conductscience.org/library/papers/38742112PubMed
1539988347Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma.J Immunother Cancer2025https://conductscience.org/library/papers/39988347PubMed
1640812667Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma.J Hepatol2026https://conductscience.org/library/papers/40812667PubMed
1737492708Application and progress of the detection technologies in hepatocellular carcinoma.Genes Dis2023https://conductscience.org/library/papers/37492708PubMed
1833510460Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/33510460PubMed
1933538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
2038162657The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy.Front Immunol2023https://conductscience.org/library/papers/38162657PubMed

See all 32 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42292467

GET https://conductscience.org/api/papers/v1/42292467/references?page=2